Parkside Financial Bank & Trust’s Achieve Life Sciences ACHV Stock Holding History

Parkside Financial Bank & Trust’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5	Closed	-$25	–	2689
2025 Q4	$25	Buy	+5	New	+$22	﹤0.01%	2671

Other funds holding ACHV

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Parkside Financial Bank & Trust's ACHV Position: Q1 2026 in Review

Parkside Financial Bank & Trust sold out of Achieve Life Sciences (ACHV) in Q1 2026, closing a stake of 5 shares — an estimated $25 sold.

Parkside Financial Bank & Trust first reported a position in ACHV in Q4 2025 and held it in 1 quarter. The position peaked at $25 in Q4 2025. 81 funds tracked by Wall St. Rank hold ACHV as of Q1 2026.

Parkside Financial Bank & Trust reported no remaining Achieve Life Sciences position as of Q1 2026 after selling out during the quarter.
Parkside Financial Bank & Trust sold 5 Achieve Life Sciences shares in Q1 2026, an estimated $25.
Parkside Financial Bank & Trust first reported a position in Achieve Life Sciences in Q4 2025 and held it in 1 quarter.
Parkside Financial Bank & Trust's Achieve Life Sciences position peaked at $25 in Q4 2025.
81 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.